Amacathera is a company that brings together commercial leaders, researchers, and biotechnology experts to develop therapeutics aimed at improving patient outcomes.

Amacathera

AmacaThera is a Toronto-based biotechnology company focused on developing and commercializing a unique, injectable hydrogel platform technology for a wide range of medical applications.

Based on the research of world-renowned biomaterials scientist, Dr. Molly Shoichet, AmacaThera is commercializing combination products at the interface of biomaterials and pharmaceuticals.

We have developed a platform technology which addresses the critical problem of sustaining therapeutic delivery of pharmacological agents for multiple disease areas. 

Currently, we have developed a combination product for post-operative pain, which is our company's lead project.

Johnson & Johnson Robotics and Digital Solutions

Viva BioInnovator

BDC Capital’s Women in Technology Venture Fund

CR Capital Management

Sprout BioVentures

StandUp Ventures

Lumira Ventures

MaRS Investment Accelerator Fund

MBX Capital

Inveready

AmacaThera

AmacaThera Updates - August 2024

Our Business Development Lead Darren Rodenhizer, PhD has prepared an update on our clinical and business development achievements so far in 2024, with an eye toward our strategy for 2025.

We have also launched a quarterly newsletter that will provide regular updates like this on our progress - you can sign up for the newsletter by visiting our website: www.amacathera.ca

AmacaThera doses First In Human Study to Evaluate, AMT-143, for Non-opioid Treatment of Post-operative Pain

Read the press release here:

https://lnkd.in/e2eaExBX

Congratulations to our Co-Founder and CSO, Molly Shoichet on being named the inaugural Pamela and Paul Austin Chair in Precision and Regenerative Medicine at the University of Toronto!

#precisionmedicine
#regenerativemedicine
#toronto

Congratulations to our Co-Founder and Chief Science Officer Molly Shoichet and team on launching BioNetHub -- $19M in funding to address the HQP shortage in #biomanufacturing.

Great presentation by Darren at Pharma Partnering Summit, San Diego

Metric
Company Name	Amacathera
Symbol
MSH ID	CA:AMACATHERA
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Biotechnology
Country	CA
Stage
Employee Count	12
Website	amacathera.ca
LinkedIn	amacathera
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

AMAC

CA:AMACATHERA

Amacathera

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue